| __timestamp | Lantheus Holdings, Inc. | Opthea Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 2652041 |
| Thursday, January 1, 2015 | 78634000 | 2361587 |
| Friday, January 1, 2016 | 75374000 | 4472869 |
| Sunday, January 1, 2017 | 92157000 | 5030957 |
| Monday, January 1, 2018 | 93326000 | 4988941 |
| Tuesday, January 1, 2019 | 103132000 | 5196412 |
| Wednesday, January 1, 2020 | 110171000 | 6652774 |
| Friday, January 1, 2021 | 218817000 | 18418247 |
| Saturday, January 1, 2022 | 233827000 | 24827066 |
| Sunday, January 1, 2023 | 267194000 | 41896408 |
| Monday, January 1, 2024 | 15488619 |
Data in motion
In the ever-evolving landscape of corporate finance, understanding cost management is crucial. Lantheus Holdings, Inc. and Opthea Limited, two prominent players in the healthcare sector, offer a fascinating study in contrasts. From 2014 to 2023, Lantheus Holdings saw a staggering 270% increase in Selling, General, and Administrative (SG&A) expenses, peaking at $267 million in 2023. This growth reflects their aggressive expansion and investment in operational capabilities.
Opthea Limited, on the other hand, experienced a more modest rise, with SG&A expenses growing by approximately 1,500% over the same period, reaching $42 million in 2023. This sharp increase highlights their strategic push into new markets and product development.
While Lantheus Holdings' expenses consistently outpaced Opthea's, the latter's rapid growth trajectory signals a company on the rise. Notably, data for 2024 is incomplete, suggesting ongoing developments in their financial strategies.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Lantheus Holdings, Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and Opthea Limited
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs Cytokinetics, Incorporated
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs PTC Therapeutics, Inc.
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Lantheus Holdings, Inc. and HUTCHMED (China) Limited
Comparing SG&A Expenses: Lantheus Holdings, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Ionis Pharmaceuticals, Inc. vs Opthea Limited: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Opthea Limited and ADMA Biologics, Inc.
Who Optimizes SG&A Costs Better? Opthea Limited or ImmunityBio, Inc.